Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 2 sales; 132 institutions reported holding it in 13F filings for Q3 2026, worth $991.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 19, 2026
- $1.06B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $5.64M in total
- 2
- 13F holdersQ3 2026, +19 vs. previous quarter
- 132
- 13F valueReported value at the end of Q3 2026
- $991.9M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$63.2M
- No comparable prior period
- Free cash flow, FY2025
- -$51.8M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 5.68M
- Shares sold short
- Change
- +478.5K
- +9.2% vs. previous
- Days to cover
- 10.51
- At average daily volume
Superinvestors holding ANRO, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding ANRO at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Alto Neuroscience, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)7:32 PM ET | Nov 16-18 | 2 days | Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | SSale | −75.0K | $27.61 | −$2.07M | −100.0%0 after | 5 lots |
| Oct 1, 2026 (view filing)9:33 PM ET | Sep 29-30 | 2 days | Smith Nicholas ConradPRESIDENT AND CFO | SSale | −134.9K | $26.45 | −$3.57M | −84.9%24.1K after | 3 lots |
| Jul 11, 2024 (view filing) | Jul 9-10 | 2 days | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +15.0K | $12.72 | +$190.8K | +60.4%39.9K after | 3 lots |
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +6.15K | $16.36 | +$100.6K | +29.7%26.9K after | 2 lots |
| Feb 8, 2024 (view filing)4:32 PM ET | Feb 6 | 2 days | Alpha Wave Global, LP and 3 others10% Owner | PPurchase | +600.0K | $16.00 | +$9.60M | +19.3%3.71M after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +1.56K | $16.00 | +$25.0K | New position1.56K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +17.0K | $16.00 | +$272.0K | +216.5%24.9K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Etkin AmitPRESIDENT AND CEO | PPurchase | +3.13K | $16.00 | +$50.0K | +0.3%1.21M after |
Top 10 13F holders, Q3 2026
See all 132 holdersThe largest institutional positions in Alto Neuroscience, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Falcon Edge Capital, LP | 3,707,757 | $94.7M | 2.22% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,726,106 | $69.6M | 0.00% | +605,097+28.5% | Added |
| Commodore Capital LP | 2,723,196 | $69.5M | 5.39% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,232,000 | $57.0M | 2.80% | +2,232,000 | New |
| Perceptive Advisors LLC | 1,760,950 | $45.0M | 0.84% | +151,057+9.4% | Added |
| Adage Capital Partners GP, L.L.C. | 1,701,913 | $43.4M | 0.06% | +101,913+6.4% | Added |
| Vanguard Capital Management LLC | 1,690,753 | $43.2M | 0.00% | +301,276+21.7% | Added |
| Spruce Street Capital LP | 1,676,558 | $42.8M | 6.81% | +323,511+23.9% | Added |
| Vivo Capital, LLC | 1,359,915 | $34.7M | 3.82% | +151,057+12.5% | Added |
| Price T Rowe Associates Inc | 1,283,867 | $32.8M | 0.00% | +925,588+258.3% | Added |
Holders of 5% or more of ANRO
See all 7 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Alto Neuroscience, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 13G/A | 9.99%4.18M shares | 0.00 ppfrom 9.99% | Oct 10, 20253 filings | Aug 14, 2026 | SEC |
| Commodore Capital LP | 13G/A | 9.90%3.59M shares | 0.00 ppfrom 9.90% | Oct 27, 20253 filings | May 15, 2026 | SEC |
| Sirenia Capital Management LP | 13G/A | 6.20%2.22M shares | −1.70 ppfrom 7.90% | May 15, 20262 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 6.00%2.10M shares | +3.90 ppfrom 2.10% | Oct 21, 20244 filings | Jul 27, 2026 | SEC |
| Armistice Capital, LLC | 13G/A | 6.00%1.62M shares | 0.00 ppfrom 6.00% | Aug 14, 20252 filings | Feb 17, 2026 | SEC |